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Introduction: The amount of pain experienced during orthodontic treatment varies 
largely over time and between individuals and can affect a patient’s compliance, ability 
to chew, well-being and sleep quality. The reasons for the inter-individual variability 
in pain are largely unknown: clinical force activation, demographic psychological 
characteristics and genetic polymorphism of candidate genes are putative factors 
that may account to explain this variability.  
 
Objective: The aim of this study was to investigate the effect of clinical, demographic, 
psychological and genetic factors on pain levels experienced during fixed orthodontic 
treatment. 
 
Method: A convenience sample of 183 patients undergoing full fixed orthodontic 
treatment at the University of Otago, Discipline of Orthodontics were recruited for 
this study. Participants pain levels were assessed seven times over a three-day period 
via a smartphone App on an issued research smart phone. Clinical, demographic and 
psychological data were collected via questionnaire. This included the Pain 
Catastrophising Scale (Child Version); the Corah Dental Anxiety Scale and the State 
and Trait Anxiety Inventory. Participants provided a DNA sample either in the form 
of blood or saliva, which were used for genotyping COMT gene rs6269, rs4680, 
rs4646310, NR3C1 gene rs2963155 and the HTR2A gene rs9316233. 
 
Results: Bond ups had the greatest influence on perceived levels of orthodontic pain, 
accounting for 20% of total variance in pain response. High pain responders had 
higher scores on pain catastrophizing (magnification subscale). Self-reported pain 
during fixed orthodontic treatment was not influenced by gender, age, time into 
treatment, anxiety, nor by polymorphisms of HTR2A or NR3C1 gene. AA genotype 




Conclusions: Orthodontic pain is stronger during bond ups and in patients with high 
catastrophizing scores. Demographics, type of clinical activations and the genetic 
polymorphisms investigated in this study had little impact on perceived pain levels.  
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Overview  
This research project is a continuation of the thesis “Genetic factors associated with 
orthodontic pain in children and adolescents: a pilot study” by a previous DClinDent 
study at the University of Otago (Student, Will Sew Hoy). This research focuses on 
demographic, clinical, psychological and genetic factors and their association with 
orthodontic pain during fixed appliance therapy in adolescents. It is divided into four 
main chapters that are organized as follows: 
 
Chapter 1 – General introduction and review of the literature  
An overview of orthodontic pain and the associated genetic and psychological 
factors will be presented. This introductory chapter includes the effect orthodontic 
pain has on patients, a brief overview of the mechanism of orthodontic pain and its 
transmission and the variables which may affect orthodontic pain. The psychological 
section will focus on anxiety and pain catastrophizing as predictors for pain 
perception during routine dental and medical treatment/conditions. The genetic 
section will focus on the COMT, HTR2A and NR3C1 genes, their association and 
roles in pain modulation, experimental pain, temporomandibular joint disorders and 
other pain related conditions. 
 
Chapter 2 – Core methods and materials 
The methodology of the study is present in the second chapter. This chapter will 
cover aspects of patient recruitment and experimental procedures. 
 
Chapter 3 – Results 
The findings of this research are presented in this chapter and is divided into three 
sections: In part one, a description of the demographics and the clinical activation 
data are presented. In part two, the genetics data are presented, whilst in part three, 
the psychological data are presented. 
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Chapter 4 – Discussion, Conclusion and future directions  
In the fourth and final chapter of this research, there will be an overview of the 
findings, the implications of this research and potential future work 
  
Chapter 5 – References  
 
Chapter 6 – Appendices  
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It has been estimated that 80% of 10-year-old New Zealand children would benefit 
from orthodontic treatment (Johnson and Harkness 2000). A more recently 
conducted survey estimated approximately 1/3 of children in the United Kingdom 
would benefit from orthodontic treatment (Harker and Morris 2005). 57% of 
Brazilian adolescents aged 10 to 17 years and 19.3% of Italian children aged 2-9 year-
old were found to be in some “need” of orthodontic treatment (Luzzi et al. 2017; 
Sharma et al. 2017). Though it is difficult to accurately measure the proportion of 
the population which would benefit from orthodontic treatment, the prevalence of 
misaligned teeth seems to be quite high. There is no doubt that orthodontic 
treatment can improve a patient’s self-esteem (Shaw, Meek, and Jones 1980) as well 
as contribute to their overall quality of life (Turpin 2007). Thus, a large portion of 
the population stands to benefit from orthodontic treatment. 
 
Pain is a very common negative aspect of orthodontic treatment (Scheurer, 
Firestone, and Bürgin 1996), some studies have shown that up to 95% of patients 
undergoing fixed orthodontic treatment experience some form of pain (Bergius, 
Kiliaridis, and Berggren 2000). Pain during orthodontic treatment is often associated 
with poor patient compliance (Sergl, Klages, and Zentner 1998); in severe cases, pain 
can cause patients to discontinue orthodontic treatment prematurely (Haynes 1967) 
and even prevent them from seeking orthodontic treatment to begin with (Oliver 
and Knapman 2014).   
 
1.2 Definitions of pain and discomfort 
 The terms pain and discomfort frequently get used interchangeably, with discomfort 
often being defined as slight pain. In reality, pain and discomfort may in fact be two 
entirely differently sensations with different domains. The sensation of discomfort 
does not necessarily involve nociception, whilst the sensation of pain always does. 
For example, the procedure of removing composite with a slow speed hand piece 
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may cause a high degree of discomfort due to the vibration, but this sensation may 
not necessarily be painful. Pain is described by the International Association for the 
Study of Pain (ISAP) as “… an unpleasant sensory and emotional experience associated 
with actual or potential damage as described in terms of such damage”. Pain is extremely 
subjective and complex, different individuals will perceive a wide range of pain 
severity even when the same stimuli is applied (Mogil 1999). This also applies in 
orthodontics, as a wide range of individual responses of discomfort are reported 
when similar forces are applied to teeth (Burnstone, 1964). Pain is in fact a very 
important response, serving as a warning or danger system to help prevent damage 
to the body. 
 
1.3 Measuring orthodontic pain and discomfort 
Since pain is extremely variable and subjective to the individual, a self-report tool is 
commonly used to assess it. There are, however, several ways for a patient to report 
their pain levels. This can be done with visual numerical scales (e.g. scale from 1 to 
10), visual categorical scales (no pain, mild, medium, moderate, intense etc.), and 
visual analogue scales (VAS). The use of a VAS is very common in orthodontic 
literature for the measurement of pain (Bergius et al. 2000; Scheurer et al. 1996). 
Some advantages of using VAS include: 1) it’s simplicity and ease of use with young 
children; 2) it’s sensitivity to small changes which has been shown to be reproducible 
(Scott and Huskisson 1979) and reliable (Revill et al. 1976). Objectively, pain can be 
measured clinically with the use of functional MRI (fMRI) (Wager et al. 2013), 
although, this approach is often considered unnecessary and impractical for research 
purposes. 
 
1.4 Mechanism of orthodontic pain 
The application of a force on a tooth usually results in the sensation of pain by the 
patient. Pain results from inflammation of the periodontal ligament (PDL), though 
irritation of the pulp may also contribute to the pain (Leavitt et al. 2002). This 
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inflammatory process is complex, but can be divided into three components; 1) 
vascular: changes in blood flow and permeability of the surrounding endothelial 
tissues; 2) cellular: recruitment of inflammatory cells e.g. neutrophils; and, 3) chemical: 
the release of chemical messengers such as histamines by the recruited inflammatory 
cells (Long et al. 2016). 
 
Upon application of a force to a tooth, one side of the PDL is compressed and local 
ischemia occurs. This causes an increase in anaerobic respiration resulting in acidosis 
and subsequent lowering of the pH levels. The surplus H+ ions bind to acid-sensing 
ion channel 3 (ASIC3) receptors that induces a painful stimulus (Gao et al. 2016). 
ASIC3 can be found in the trigeminal ganglion, when activated, they stimulate the 
trigeminal neurons to release neurological mediators such as calcitonin gene-related 
peptide (CGRP) and Substance P (Long et al. 2015; Yamaguchi et al. 2009). Locally, 
the lower pH environment and ischemia stimulates the endothelial cells to release 
nitric oxide (NO). CGRP, substance P and NO act to increase vascular permeability, 
cause local vasodilation and increase the inflammatory response. The increased 
vascular permeability allows for the recruitment and accumulation of neutrophils, 
lymphocytes, and monocytes (Scott and Krauss 2012; Zeng et al. 2015), which upon 
recruitment and activation into the inflammation site releases chemokines and other 
inflammatory mediators. This amplifies the inflammatory response and causes pain 
(Gameiro et al. 2015).  
 
The inflammatory mediators (e.g. cytokines, prostaglandins) further act on the PDL 
to increase its sensitivity to pain (Shanfeld et al. 1986). As a result, the PDL is 
sensitized to algogens such as histamines, prostaglandins, bradykinins etc.  (Ferreira, 
Nakamura, and de Abreu Castro 1978). 
 
The transmission of orthodontic pain to the cortex occurs via three-order neurons. 
The first order neuron located at the trigeminal ganglia is a pseudo unipolar neuron. 
This neuron contains both peripheral processes and central processes. The 
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peripheral process travels to the periodontal tissue, face etc, whilst the central 
process runs to synapse with the second order neuron, the trigeminal nucleus 
caudalis (located in the medulla oblongata). Unlike the peripheral parts of the rest 
of the body (such as arms), the neurons do not synapse in the spinal cord. It is in 
the medulla oblongata that the second order neurons decussate and cross over to 
the contralateral side, from here the second order neurons will continue up the 
medulla oblongata and synapse with the third order neurons in the ventroposterior 
nucleus of the Thalamus. Here the third order neurons will ascend into the areas of 
the cortex such as the hippocampus, somatosensory cortex, amygdala etc. which 
elicits both a physical and emotional response to pain (Long et al. 2016).  
 
1.5 Effects of pain and discomfort on patients 
Orthodontic treatment is associated with pain and with large inter-individual 
variation in pain perception. It is generally accepted that there is a delayed onset of 
pain following placement or adjustment of fixed orthodontic appliances, with some 
reporting a pain free period of approximately two to four hours after adjustments 
(Firestone, Scheurer, and Bürgin 1999; Furstman and Bernick 1972; Ngan et al. 
1989). Pain has been shown to be the worst 24-48 hours after treatment, and then 
gradually decreases and returns to baseline within five to seven days (Jones and Chan 
1992; Ngan et al. 1989).  
 
Almost every patient reports some pain upon eating or chewing following the 
placement of fixed orthodontic appliances (Scheurer et al. 1996). In certain 
circumstances, patients report that the pain associated with eating hard foods is 
enough to warrant a temporary change of diet to foods of softer consistency 
(Krishnan 2007; Scheurer et al. 1996). 
 
Night disturbances as a result of pain in the first two nights after initial placement of 
fixed orthodontic appliances is quite common, and ranges from 13% to 22% of 
patients (Jones and Chan 1992; Kvam, Gjerdt, and Bondevik 1989; Scheurer et al. 
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1996). Overall, it seems roughly 20% of patients have their sleep disturbed due to 
pain and are woken to take pain relief as a result. However, this generally occurs 
only in the first two nights following treatment, after which, patients adapt quite 
readily. In extreme cases, pain is severe enough that patients discontinue orthodontic 
treatment, though this area has not been investigated thoroughly. The porportion 
patients whom discontinue treatment as a result of pain is reported to be between 
8% and 30% (Polat 2007). 
 
1.6 Variables affecting orthodontic pain 
There is wide inter-individual variability of pain perception between orthodontic 
patients when a similar stimulus is applied (Mogil 1999). Initially, pain perception was 
thought to be dependent of the amount of force applied i.e. higher forces resulted 
in higher pain levels (Burstone, 1964), thus believing that lighter forces led to less 
discomfort. This has been rejected by most studies, which have found no difference 
in patient pain scores between different arch wires used (Hixon et al. 1969; Johnston 
and Boester 1972; Jones and Richmond 1985; Ong, Ho, and Miles 2011; 
Papageorgiou et al. 2014). However, there are some studies which have reported 
that higher force levels result in higher pain levels (Luppanapornlarp et al. 2010; 
Singh et al. 2019), these two studies concluded that the use of 150 grams of force 
for tooth movement resulted in more pain and inflammation compared to 50 grams.  
  
There is some controversy on whether self-ligating brackets are less painful 
compared to traditional brackets with active ligation (Bertl, Onodera, and Čelar 
2013).  
 
Some authors have reported similar pain perception between genders (Jones 1984; 
Ngan et al. 1989), whilst others have found that females report a higher level of pain 
(Kvam et al. 1989; Scheurer et al. 1996). Whether age affects patient pain experience 
is controversial since it can be difficult to assess pain levels between age groups due 
to a difference in patient’s perception and understanding of pain/discomfort over 
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time. Some studies found that patients between the ages of 13-16 years had the 
highest pain frequency (Scheurer et al. 1996), but the mean pain intensity did not 
differ from the other age groups. Brown and Moerenhout (1991), reported that the 
14-17 years old age group was the most susceptible to pain.  
 
1.7 Psychological factors 
Early theories of pain primarily focused on the physiological side of pain. For 
example, the model proposed by Descartes’ indicated that pain intensity was directly 
related to the amount of tissue damage (Sullivan et al. 2001). There is no doubt that 
an association exists between the amount of tissue damage and pain intensity, 
however, physiological based models alone are unable to explain the wide range of 
pain perception (Beecher 1956). More recently, there has been a shift away from a 
purely physiological model towards a psychological model. It is now more commonly 
accepted that psychological factors are more important determinants of pain 
perception (Turk and Rudy 1992). 
 
Not surprisingly, the psychological well-being of individuals can have an impact on 
pain perception (Brown and Moerenhout 1991). It is difficult to fully assess an 
individual’s psychological state as there are too many variables which not only vary 
from day to day but also change over time (Jivraj et al. 2014; Springer, Pudrovska, 
and Hauser 2011; Steptoe, Deaton, and Stone 2015). However, there are certain 
psychological states and traits which may influence an individual’s pain perception. 
Pain catastrophizing, depression, anxiety, fear, previous painful experiences are all 
psychological states or traits which can increase an individual’s perception of pain 
(Han and Pae 2015; Klages et al. 2004; Martin et al. 2007; Sullivan et al. 2001). 
Conversely, relaxation and distraction techniques, as well as confidence and 
assurance from the health provider (such as a phone call the day after the 
procedure) have been shown to decrease an individual’s perception of pain (Bartlett 
et al. 2005; Corah, Gale, and Illig 1979). 
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1.7.1 Dental anxiety 
Anxiety is often described as an unpleasant sensation about unknown and unfamiliar 
process. Dental anxiety is specific to a patient’s stress response in a dental situation 
(Mohammed et al. 2014). Dental fear or anxiety is ranked the 5th most common 
fearful situation (Agras, Sylvester, and Oliveau 1969) with 20% to 25% of adults 
reporting delays in visiting a dentist due to dental fear (Boyle, Newton, and Milgrom 
2009; Smith and Heatom 2003). The prevalence of moderate dental anxiety is 
generally accepted to be between 10% and 20% of the general population (Locker 
et al. 1999; White, Giblin, and Boyd 2017), though some studies have reported this 
number to be as high as 80% in a clinical setting (Dou et al. 2018). Generally speaking, 
there is a trend for dental anxiety to decrease with age with adolescents being less 
fearful of the dentist compared to children (Locker et al. 1999; Majstorovic and 
Veerkamp 2005). This trend seems to carry on into adulthood (Dou et al. 2018). 
Females have been shown to consistently have a higher prevalence of dental anxiety 
(White et al. 2017). Dental anxiety is usually measured using patient questionnaires, 
with the most common being a 4-item questionnaire developed by Norman L. 
Corah in 1968. This simple to use questionnaire has been shown to be both reliable 
and valid (Corah 1969). Dental anxiety has been shown to be positively correlated 
with a patient’s pain perception during orthodontic treatment (Bergius et al. 2008), 
routine scaling and cleaning (Sullivan and Neish 1998), dental injections (van Wijk 
and Hoogstraten 2009) and general dental treatment (Klages et al. 2006; Vassend 
1993).  
 
1.7.2 Pain catastrophizing 
Pain catastrophizing is described as a “negative cognitive-affective response to 
anticipated or actual pain” (Quartana and Edwards 2009) or “a set of negative 
emotional and cognitive processes” (Sullivan et al. 2001). In simpler terms it’s meant to 
describe those who exaggerate pain experience more so than the average person, 
including those who are highly anxious and worried about any perception of pain. 
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Pain catastrophizing is often characterized by a tendency to magnify the painful 
stimulus, feel helpless in the presence of a painful event and ruminate on the pain. 
Pain catastrophizing is usually measured using a 13-item questionnaire (Sullivan, 
Bishop, and Pivik 1995). A total score is calculated which range from 0-52, with 
different questions measuring the three sub-scales; “rumination”, “helplessness” and 
“magnification”. It is interesting to note that these sub scales may well be very useful 
in predicting pain and disability in certain conditions; for instance, the subscale 
“magnification” has been  shown to be the best predictor of pain and disability in 
patients with whiplash approximately 1 year after injury (Sullivan et al. 2002). On 
the other hand, the subscale “rumination” has been shown to be the best predictor 
for patient perceived disabilities following soft tissue injury (Sullivan et al. 1998) and 
was highly associated with higher pain experiences during dental hygiene 
appointments (Sullivan and Neish 1998). The subscale “helplessness” was shown to 
be the best predictor for the severity of functional disability following chronic lower 
back pain (Vienneau et al. 1999). Pain catastrophizing has not been well studied 
during orthodontic treatment; however, a study conducted at the University of 
Otago assessed patients pain levels after the placement of separating elastics found 
high pain responders consistently had higher pain catastrophizing scores (Beck 
2013). Classifying individuals as a non-catastrophizer or catastrophizer can be difficult 
as there is no determinant cut-off score and the chances of misclassification would 
be high. Accordingly, most researchers agree that catastrophizing is best treated as 
a continuous variable and not a categorical variable (Sullivan et al. 2001). High levels 
of pain catastrophizing have been linked to depression, altered pain perception, 
disabilities as a result of pain and increased expression of pain (Edwards et al. 2006; 
Sullivan et al. 2001). Pain catastrophizing is believed to account for 7% to 31% of 
pain variability (Sullivan et al. 2001). 
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1.8 Genetic factors 
To date, the only study that can be found on this topic had investigated the 
association between certain genetic polymorphisms and patient pain experience 
during fixed orthodontic treatment (Sew Hoy 2017). Polymorphisms of the COMT 
(Catechol-O-methyltransferase), NR3C1 (a Glucocorticoid) and HTR2A (a 
serotonin receptor) were investigated in this preliminary study. More specifically, 
polymorphism of rs6269, rs4680, rs464310 SNP of the COMT gene, rs2963155 
SNP of the NR3C1 gene and rs93116233 SNP of the HTR2A were investigated. 
Results of the pilot study showed that participants with AA genotype of the 
rs464310 SNP of the COMT gene experienced almost three times the total resting 
pain compared to the AG and GG genotypes, whilst the CG genotype of the 
rs93116233 SNP of the HTR2A gene experienced almost double the total chewing 
pain (Sew Hoy 2017). These findings suggest that genetic factors do in fact play a 
role in patient’s pain experience during orthodontic treatment. However, the study 
did not have enough statistical power to determine if there were any statistical 
differences between the pain experienced by participants of other SNP’s of the 
mentioned candidate genes. 
 
There are, however, other studies reporting associations between single nucleotide 
polymorphisms and experimental pain (Diatchenko et al. 2006), pain associated with 
fibromyalgia (Gürsoy et al. 2003), orofacial pain and temporomandibular joint 
disorders (Diatchenko et al. 2005). 
 
1.8.1 COMT gene 
The COMT gene is found on the long arm of chromosome 22 and codes for the 
enzyme Catecholamine-O-Methyltransferase. COMT is one of several enzymes 
involved in the degradation of catecholamines (such as dopamine, adrenaline, 
noradrenaline) as well as catechol estrogens and other substances which have a 
catechol structure. More specifically, Catecholamine-O-Methyltransferase catalyzes 
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the transfer of a methyl group from S-adenosylmethionine to a catechol substrate 
which results in the production of S-adenosyl-L-homocysteine and O-methylated 
catechol. The production of O-methylated catechol is one of the major degradation 
pathways for these catechol substrates. The COMT gene codes for two versions of 
Catecholamine-O-Methyltransferase; a longer form, known as membrane-bound 
Catecholamine-O-Methyltransferase (MB-COMT) which is predominantly 
produced by the nerve cells found in the brain; and a shorter form, known as soluble 
Catecholamine-O-Methyltransferase (S-COMT), which is produced by other tissues 
such as blood, liver and kidneys (Lundstrom et al. 1991; Tenhunen et al. 1993).  
Compared to S-COMT, MB-COMT is found in higher concentrations in the brain 
and have a higher affinity for dopamine and adrenaline (Lotta et al. 1995), thus 
making it more suitable for the degradation of catecholamines in the brain. 
 
The COMT locui that code for MB-COMT and S-COMT is noticeably different, as 
a result the location of the same SNPs on the loci of the two forms may also differ.  
As shown in Figure 1.1 (adapted from Diatchenko et al 2005). 
 
 
Figure 1.1 Various SNP locations on Membrane bound and Soluble forms of the COMT gene. Adapted from 






The COMT gene is perhaps the most well studied gene in relation to pain 
perception, with most of the SNP’s associated with the COMT gene found in non-
coding regions that do not alter the actual amino sequence of the COMT enzyme. 
However, these SNP’s can still have an effect on the processes of DNA transcription, 
RNA splicing, mRNA stability, mRNA transport and mRNA transcription (Andersen 
and Skorpen 2009). 
 
One of the most researched SNP’s of the COMT gene is rs4680, which results in 
the replacement of the amino acid valine (Val) to methionine (Met) at codon 108 
for S-COMT and codon 158 for MB-COMT. The substitution leads to an enzyme 
which has lower thermostability and a resultant three to four-fold decrease in 
enzymatic activity. The SNP found at rs4680 is co-dominant; with val/val genotypes 
display the highest amount of COMT enzyme activity; whilst, met/met genotypes 
display the lowest amount of activity. Heterozygous genotypes (val/met) are found 
to display a moderate level of COMT enzyme activity. Higher activity of the COMT 
enzyme is associated with lower pain perception and vice-versa. Like with every 
pathway, the body compensates for the varying levels of the COMT enzyme activity; 
in circumstances of high COMT enzyme activity (such as with val/val genotypes), 
there is resultant reduction in the activation of the D2 receptors. The reduction in 
the activation of D2 receptors results in a reduction of neuronal content of 
enkephalin peptides, a compensatory decrease in the number of µ-opioid receptors 
but an increased capacity to activate them. The reverse is also true in circumstances 
of low COMT enzyme activity, where there is a clinically reduced analgesic effect by 
endogenous opioids (Zubieta et al. 2003). 
 
Diatchenko et al 2005 separated test subjects into three major haplotypes; LPS (low 
pain sensitivity), APS (intermediate pain sensitivity) and HPS (high pain sensitivity), 
these three major haplotypes are based off four common SNP’s of the COMT gene; 
rs6269, rs4633, rs4818 and rs4680. These three major haplotypes accounted for 
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96% of the examined genotypes and for 11% of the variances in pain perception in 
this study group. Multiple SNPs of the COMT gene have a synergistic effect, which 
has a larger influence on COMT enzyme activity than any singular SNP alone 
(Shifman et al. 2002). This synergism appears to exert it’s effect via influence of the 
translation process and/or the stability of the mRNA (Diatchenko et al. 2005). 
The  COMT gene has also been associated with TMD and differences in pain 
perception (Diatchenko et al. 2005; Lee et al. 2011). SNPs associated with higher 
levels of COMT activity are associated with a lower perception of pain and vice-
versa (Diatchenko et al. 2005; Duan et al. 2003).  
 
1.8.2 HTR2A gene 
The HTR2A gene is located on chromosome 13 and codes for a serotonin G-
coupled membrane receptor protein. The serotoninergic system, of which serotonin 
is the main neurotransmitter, has many functions such as reward, learning and 
memory, but perhaps it is mostly known as a contributor to a feeling of well-being 
or happiness. Abnormalities in the serotoninergic system has been identified in 
patients with fibromyalgia (Wolfe et al. 1997), whilst serotonin re-uptake inhibitors 
have been shown to be effective in treatment of fibromyalgia (Dwight et al. 1998), 
which further supports the importance of the role that serotonin plays in pain 
management. Serotonin has been shown to have an anti-nociceptive role via the 
spinal cord, through the descending pathway of the dorsal horn (Mense 2000).  
HTR2A has not been studied extensively as the COMT gene, and the literature is 
quite scarce. However, rs12584920 SNP of HTR2A has been associated with 
musculoskeletal pain (Nicholl et al. 2011); whilst, rs9316233 SNP has been shown 
to be associated with temporomandibular joint disorders, with the minor allele G 
offering a protective effect against TMD risk (Smith et al. 2011).  
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1.8.3 NR3C1 gene 
NR3C1 gene is located on chromosome 5 and codes for a glucocorticoid receptor. 
This receptor is involved in the primary endocrine stress axis in humans, and as 
stress plays an important role in pain perception, it is not unreasonable to assume 
polymorphisms of NR3C1 may affect pain levels. The evidence for the role of this 
gene in this function is, however, weak. A recent study found no association between 
SNPs of NR3C1 and musculoskeletal pain (Nicholl et al. 2011), though it has been 
previously associated with Chronic Fatigue Syndrome (Rajeevan et al. 2007) and 
TMD (Smith et al. 2011). 
 
5-hydroxytryptamine receptor 3B (5-HTR3B) is a G-coupled membrane receptor 
responsible for a wide variety of functions including serotonin and dopamine 
signaling (McBride et al. 2004). rs1176744 SNP of 5-HTR3B has been associated 
with pain catastrophizing scores, which in turn have been associated with differences 
in perception of pain and in activity levels of the brain pertaining or linked to pain 
(Gracely et al. 2004). Therefore, it is likely that this SNP of 5-HTR3B is associated 
with the perception of pain during orthodontic treatment. However, 5-HTR3B 
receptor is not tested in this study, instead SNP of HTR2A gene which encodes for 
another G-protein coupled receptor was investigated due its association with 
temporomandibular joint disorders. 
 
The Orofacial Pain: Prospective Evaluation and Risk Assessment (OPPERA) is a large 
study that has been carried out in United States for patients aged between 18 and 
44 years of age to assess the risks and incidence of TMD amongst other things (Bair 
et al. 2013). This project had an impressive sample size of 186 TMD subjects and 
3,263 subjects in total and has literature on the association genetics and orthodontic 
pain is largely non-existent, genetic influence with TMD was the closest relatable 
field and in this regard, the OPPERA study has been a significant inspiration for this 
study. The OPPERA identified SNPs of NR3C1 (rs2963155) and HTR2A 
(rs9316233) to be associated with temporomandibular joint pain (Smith et al. 2011). 
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rs4680 SNP of COMT is perhaps the most well studied, and has been associated 
with sustained muscular pain (Zubieta et al. 2003), headaches (Hagen et al. 2006), 
experimental pain (Diatchenko, Nackley, et al. 2006), migraine (Emin Erdal et al. 
2001), and fibromyalgia (Gürsoy et al. 2003). rs6269 SNP and rs4646310 SNP of 
the COMT gene has been associated with experimental pain (Diatchenko et al. 
2005), the latter has also been associated with temporomandibular joint pain 
(Michelotti et al. 2014). It is for these reasons, that these SNPs were selected for 
the pilot study. 
  
Previous studies at the University of Otago have shown that rs6269 SNP of the 
COMT gene is associated with differences in pain perception after the placement of 
orthodontic separator rings (Beck et al. 2014). The  preliminary results for this study 
has showed that patients with rs4646310 SNP of the COMT gene as well as 
rs9316233 SNP of the HTR2A gene was associated with differences in pain 
perception during orthodontic treatment (Sew Hoy 2017). No significant difference 
in pain perception was found with rs4680 and rs4646310 SNPs of the COMT nor 
in the rs2963155 SNP of the NR3C1 gene in the pilot study. 
 
1.9 Managing orthodontic pain and discomfort 
Orthodontic pain is usually managed with analgesics such as paracetamol and 
NSAIDs such as ibuprofen. There is some controversy in the literature over which 
pharmacological substance is the best for pain relief, with some studies reporting 
that NSAIDs and paracetamol are both equally effective (Angelopoulou, Vlachou, 
and Halazonetis 2012). Other studies have found that NSAIDs such as ibuprofen 
are more effective, and that paracetamol does not significantly differ from a placebo 
when used for relief or orthodontic pain (Patel et al. 2011). 
 
It has been suggested that the pre-operative use of NSAIDs helps to reduce 
orthodontic pain (Bernhardt et al. 2001; Kohli and Kohli 2011; Law et al. 2000) by 
first allowing the body to absorb and distribute the drug, and secondly by inhibiting 
16 
the inflammatory response before it occurs and thus help to reduce central nervous 
system sensitization (Woolf 1991). The inflammatory response that arises from 
orthodontic forces are the driving force behind tooth movement, and therefore, 
there is still debate over whether the use of NSAIDs inhibit tooth movement. The 
general consensus is that low doses of NSAIDs over one or two days during 
orthodontic treatment will not significantly affect tooth movement (Krishnan 2007).  
 
The use of chewing gum or wafers during the first few hours of treatment have 
been shown to reduce the amount of discomfort perceived in 63% of patients 
(White 1984). Continuous masticatory forces immediately following treatment is 
believed to cause movement of the tooth so as to relieve the compressed PDL 
space and allow sufficient blood flow to this area, which in turn reduces buildup of 
metabolic by-products (Proffit and Fields, 2000). 
 
A recent Cochrane review conducted by Monk et al 2017 consisting of 32 
randomized control trials and 3110 participants concluded that analgesics are 
effective for reducing pain following orthodontic adjustments. However, the review 
failed to find any substantial evidence that pre-operative NSAIDs were more 
effective than post-operative NSAIDs, nor did they find any significant difference in 
pain relief between the different analgesics used. As stated previously, there is often 
a pain-free period of two hours following orthodontic adjustments, which may 
explain the lack of evidence found for the effectiveness of pre-operative NSADs. It 
is also prudent to remember that absence of evidence is not necessarily evidence of 
absence.    
 
Low-level laser therapy has been used in the medical and dental fields for various 
reasons. More recently, it has been adapted for orthodontic purposes, where whole 
dental arches are irradiated with low-level lasers, it’s supposed benefits include 
accelerated tooth movement (Kim, Chou, and Park 2015) and reduction in 
orthodontic-related pain (Bicakci et al. 2012). For orthodontic pain relief, a Diode 
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laser is often used, with a wavelength in the low 800nm range, and power outputs 
varying from 0.7mW to 150mW. Some studies have shown promising results in the 
alleviation of pain post orthodontic adjustment (Bicakci et al. 2012; Doshi-Mehta and 
Bhad-Patil 2012; Tortamano et al. 2009), whilst other studies have shown no 
difference (AlSayed Hasan, Sultan, and Hamadah 2018; Celebi, Turk, and Bicakci 
2019). Currently, there is not enough evidence to advocate it’s use in orthodontics 
to relieve pain (Ren, McGrath, and Yang 2015). The use of the Diode laser for pain 
relief can be impractical for orthodontic offices, as the procedure may take well over 
30mins per patient. 
 
Interestingly, a phone call from the treating orthodontist 24 hours after treatment 
has been shown to reduce patient reported levels of pain and anxiety. However, 
the same does not apply when the same phone call is made by the receptionist or 
dental nurse. A reasonable explanation seems to be that a phone call helps to reduce 
a patient’s anxiety, which in turn reduces the patient’s self-reported levels of pain 




To investigate the relationship between demographic, clinical, psychological and 
genetic factors with the severity of pain experienced by patients undergoing fixed 
orthodontic treatment at the University of Otago. 
 
1.11 Objectives 
1. To investigate the relationship between age, gender, ethnicity, and type of 
clinical activations, with patient’s self-reported pain whilst undergoing fixed 
orthodontic treatment. 
2. To investigate the relationship between psychological traits/states (such as 
pain catastrophising, dental anxiety, generalised anxiety) and orthodontic 
pain 
3. To determine whether certain genotypes/haplotypes of the COMT, HTR2A 
and NR3C1 genes are associated with the severity of pain experienced by 
patients undergoing fixed orthodontic treatment at the University of Otago. 
 
1.12 Hypothesis 
1. Pain experienced during orthodontic treatment is influenced by 
demographic and clinical factors 
2. Patient’s with higher dental anxiety, generalised anxiety and pain 
catastrophising scores will report higher pain experiences whilst undergoing 
fixed orthodontic treatment.  
3. The severity of pain experienced by patients undergoing fixed orthodontic 
treatment is associated with certain genotypes/haplotypes of COMT, 











Assessment of pain 






2.1 Research approach 
This research is a direct continuation of the DClinDent thesis titled “Genetic factors 
associated with orthodontic pain in children and adolescents: a pilot study” by 
William Sew Hoy (2017). As such the methods and research approach is very similar. 
The study follows a prospective longitudinal study design using the STROBE 
guidelines (von Elm et al. 2008). The participants for this research were recruited 
from a pool of participants that had already been enrolled in an ongoing genetics 
study within the Sir John Walsh Research Institute, University of Otago. A post hoc 
analysis for not performed for this study.  
 
2.2 Study sample 
A convenience sample of 183 patients (including 82 from the pilot study) undergoing 
fixed orthodontic therapy at the orthodontic clinic, Faculty of Dentistry, University 
of Otago participated in this study. Patients recruited for this study were contacted 
by phone or approached in the clinic. The study comprised of 98 females (53.5%) 
and 85 males (46.5%) with an average age of 14.8 years. 
 
2.3 Inclusion criteria 
Participants were included if they were: 
1) Currently undergoing, or about to commence orthodontic treatment with 
full fixed appliances in at least one arch 
2) Younger than 18 years of age 
3) Willing to participate and provide informed consent  
 
2.4 Exclusion criteria 
Participants were excluded if they had: 
1) Craniofacial syndromes such as cleft lip and/or palate 
2) Undergoing orthognathic surgery 
3) A diagnosed depressive disorder 
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4) Any chronic pain syndrome 
5) Used any neurological-acting medication or medication that could potentially 
affect pain sensitivity e.g. antidepressants 
6) Active caries or periodontal disease 
 
Participants were provided with an explanation of the goals, procedure and 
instructions of the research both verbally and via a printed handout. The primary 
investigator’s email address was provided to participants should any concerns arose 
during the research.  
 
2.5 Smartphone app   
Traditionally, orthodontic pain studies have used paper based visual analogue scales 
(VAS). The use of paper VAS has the potential for recall bias as it is impossible to 
determine when the VAS scores were completed. Furthermore, participants can 
also view their past scores, which may influence their current evaluation of their 
current pain levels. The smartphone app which was designed for use in the pilot of 
this study only allowed the participants to input their data three hours prior to and 
three hours after the set time. If no data was entered during this six-hour window, 
a missing score would be placed. In order to increase the likelihood that the 
participants would complete the questionnaires on time, the app was designed to 
send audio alerts when the questionnaire was to be completed. The exact time of 
when the participant filled out the questionnaire was also recorded; this ensured the 
participants filled out the questionnaire at the correct times and reduced the chance 
of recall bias. To ensure that participants were not influenced by their previous pain 
scores, the app did not allow the participants to review their previous entries. 
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2.5.1 Technical details of app development 
The Android pain app entitled “My Braces Experience” was developed using the 
Eclipse integrated development environmental software (Luna version 4.4.21) with 
Android Eclipse Plugin to target Android versions 3.0 to 6.0.  
The app utilized the Android notification system (including a vibration, audio cue and 
a text display) at the scheduled questionnaire times. The app could be launched 
either from the smartphone’s application list or via clicking the notification reminder 
to complete the questionnaire.  
 
Participants navigated through each page of the questionnaire and answer them with 
the use of the default android onscreen keyboard, number pad or touchscreen.  
Questionnaire answers were stored on a local database (SQLite2) at the completion 
of each session. Once all the sessions were completed, the data were retrieved from 
the database, complied into a single comma-separated-values file and emailed to a 
Google Mail account using the JavaMail API3. The file could then be downloaded and 
analyzed. If the app was unable to detect an internet connection when attempting 
to send the email, it would prompt the user with a notification to connect to the 
internet from within the app, and this notification would continue to appear until 
internet connection was established. 
 
2.5.2 Testing phase 
Previously, the app had been validated by the previous primary investigator (Will 
Sew Hoy) on all available ten research phones (Vodafone Smart Prime 6 with a 5” 
color display) for bugs and/or malfunctioning of the app or any data inaccuracies of 
the exported data file compared to the actual data input. Two issues that were 






down or b) ran out of power before the file was emailed to the researcher. An 
updated version of the app was released on the 14th October 2017 that fixed both 
these issues, and under ideal testing conditions, the current researcher found that 
the update did indeed resolve the two issues mentioned above. The smartphone 
app was only functional on the research Vodafone Smart Prime 6 android phones. 
 
2.5.3 App-related issues encountered during the study 
During the initial stages of data collection, it was identified that the retrieved data 
set was incorrect if the app was not uninstalled and reinstalled between participants. 
This resulted in data collection having to be repeated in the first 20 participants. 
Despite the app being updated and been tested, the data was again lost if the phone 
shut down or ran out of power prior to sending the complete data set. “null” values 
were found in the export data which did not correspond to any possible data-entry 
during the testing phase, it was found that the input data and export data differed 
greatly if the “null” value was found in the export data. An issue was encountered 
with the app in where the entered data was lost for unknown reasons: this issue 
was reported to the app developer but could not be repeated during testing.  
 
2.6 Experimental procedure 
This study was conducted in two phases. In the first phase, the patient’s demographic 
information and DNA sample were collected. The demographic data and DNA 
samples were used for this research as well as another ongoing genetic research 
within the Sir John Walsh Research Institute, University of Otago. In phase two, the 
patients were asked to complete a few psychological questionnaires and then use 
the smartphone app to assess their pain levels over the next three days after the 
participant’s fixed appliances were adjusted. 
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2.7 Phase one 
Participants and the participant’s mother were asked to complete a self-reported 
questionnaire regarding their sociodemographic details (e.g. age, gender, ethnicity). 
Study participants were asked to provide a DNA sample preferably in the form of 
a blood sample, however, if this was refused, the participants were asked to provide 
a saliva sample instead. A blood sample was much preferred over a saliva sample as 
it provided a much greater quantity and quality of DNA. Indeed, saliva samples were 
much more likely to fail in genotyping compared to blood samples. A registered 
nurse/Phlebotomist collected the blood samples on-site using standard venipuncture 
procedures. The collection of blood samples was later allocated to Southern 
Community Laboratories, whilst the saliva sample was collected by the primary 
investigator (WL). The blood samples included a 10mL EDTA tube that was used 
for DNA preparation, and a 5mL gold top SST for the serum. The SST vacutainers 
were centrifuged at 3,500 rpm. A 10mL saliva sample was taken using DNA 
genotekTM Oragene-500 kits when the blood sample was refused. All DNA samples 
were then transported to Merriman Laboratories (University of Otago) for storage 
and DNA extraction. 
 
2.8 Phase two 
Patients were recruited for this study from the pool of participants collected in 
phase one. Only participants who were undergoing or about to undergo fixed 
orthodontic treatment by postgraduate orthodontic students at the University of 
Otago, Faculty of Dentistry, Department of Orthodontics were asked to participate 
in this study. 
 
At the participant’s adjustment appointment, the participants were asked to 
complete a seven-page questionnaire which included the Pain Catastrophizing Scale 
for Children, the Corah Dental Anxiety Scale and the State-Trait Inventory for 
Children (Appendix 6.1). Following the completion of the questionnaire and 
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orthodontic adjustment, participants were issued with an Android Smartphone 
(Vodafone Smart Prime 6 with a 5” color display), and Wrigley’s Extra chewing gum 
(peppermint or spearmint flavor). The participants were then logged onto the “my 
braces experiences” pain app and completed the baseline questionnaire under the 
supervision of the primary investigator (WL). The primary investigator explained 
each question to the participant as they answered them. Participants were also given 
an information sheet regarding the details of the app and the times to complete the 
questionnaires. The primary investigator’s (WL) email was also given, should any 
concerns have arisen (Appendix 6.2). 
 
A visual analogue scale was used to assess the participants pain experience (Figure 
2.1). The traditional paper VAS scale was adapted into a digital format, measuring 
9.35cm long. Participants were asked to use their fingers to drag a small dot to a 









The participants were asked to complete the questionnaire session a total of seven 
times over the next three days; 1) at baseline; 2) 8pm on the first evening; 3) 8am 
on the second morning; 4) 8pm on the second evening; 5) 8am on the third morning; 
6) 8pm on the third evening; and 7) 8am on the fourth morning. Overall, the 
participants completed questionnaires regarding their pain over a period of roughly 
74 hours following their orthodontic adjustment. An audio alert sounded at all seven 
of the previously mentioned time points to alert the participants to complete the 
questionnaire session. The participants were only able to complete the questionnaire 
 






session three hours prior to and up to three hours after the time points mentioned. 
Participants were not permitted to complete the questionnaires outside these times.  
The participants were asked a variety of questions during each session of the 
questionnaire, and included; whether they had taken any pain relief as well as the 
type of pain relief taken; resting pain of their teeth currently; orofacial pain; 
headaches; and teeth pain immediately after chewing a piece of gum twenty times 
(Wrigley Extra, peppermint or spearmint flavor). For a full flow-chart of the 
questionnaire please refer to Appendix 6.3. The participants were instructed to 
chew the gum with twenty chewing strokes, but no specific information was given 
on how to chew the gum e.g. on their front teeth, back teeth, left or right-hand side. 
The type of orthodontic adjustment (i.e. details of the adjustment at the 
appointment) and time into treatment was not standardized. For example, it was 
not possible for every participant to record their pain following a bond-up with fixed 
orthodontic appliances. Details of adjustment appointment e.g. wire change, use of 
elastics etc. as well as the patients time into treatment was recorded. Participants 
were instructed to return the issued research phones to the orthodontic 
department right after they had completed their final questionnaire. Participants 
were reminded to return their research phones via a phone call one day before the 
last questionnaire were meant to be completed.  
As an incentive to complete and participate in the research, patients were offered a 


















2.9 Data storage 
2.9.1 Storage of questionnaires 
Hard copies of both questionnaires completed in phase one and phase two of the 
study were kept in a secure storage location within the Faculty of Dentistry, 
University of Otago. These questionnaires will be retained for up to 10 years at the 
location stated above. Only the investigators of this research will have access to 
these questionnaires.  
 
2.9.2 Storage of DNA Samples 
The DNA samples will be stored securely for up to 10 years in the Merriman 
Laboratories at the Biochemistry Department at the University of Otago. Only the 
investigators of this research will have access to these samples. No other external 
source, commercial or non-commercial will have access to any of this information 
without the consent of the study’s participants/parents. 
 
2.9.3 Storage of pain application data 
The data from the pain application was automatically emailed to a secure Gmail 
account and downloaded to a secure serve for safe keeping and storage. Only the 
investigators of this study had access to this Gmail account.  
 
2.10 Missing data 
A missing score was placed for each pain questionnaire session which were either 
1) not fully completed or 2) not completed within the allocated timeframe. 
Participants were only included in the research if they had fully completed at least 
five of the seven pain questionnaire sessions i.e. had no more than two missing data 
sessions. For participants who had missing scores for one or two pain questionnaire 
sessions, the last observation carried forward method was used to fill in these missing 
data. That is, the last complete pain questionnaire session answers prior to the 
missing data was used to replace the missing data e.g.  if pain questionnaire session 
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seven’s data were missing, then they were replaced by the data from pain 
questionnaire session six. However, in the case that the second questionnaire session 
was not complete, an alteration had to be made to the last observation carried 
forward method to compensate for question three (refer to Appendix; 6.3 “Flow 
of “My Braces Experience” application, p.98, Figure 24), question three was not 
asked at the baseline. In order to fill in this specific missing data (question three) the 
peak score (highest score) of all answered question three data was taken. 
 
2.11 Assessment of pain 
The collected VAS scores were expressed as a percentage (0-100) of the 9.35cm 
scale. 
Participant pain levels over the seven sessions were analyzed using three methods: 
1) as an average of the pain over the seven sessions; and 2) as cumulative pain, that 
is the addition of the reported pain over the seven sessions; and 3) as the peak 
(highest reported) pain. Three self-reported pain measurements from the survey 
were used; 1) current pain at teeth; 2) maximum pain; and 3) pain after chewing 
gum (Wrigley’s extra chewing gum). Current pain at teeth were derived from 
question two of the pain survey: “On the line below, move the slider to describe 
the current pain level at your teeth. Maximum pain was derived from question three 
of the pain survey: “On the line below, move the slider to describe the maximum 
pain level experience at your teeth since the last questionnaire”. Question three is 
only asked from session two onwards. Pain after chewing was derived from question 
six of the pain survey: “On the line below, move the slider to describe the maximum 
pain level experienced at your teeth while chewing the gum”. Question six of the 
pain survey was asked directly after the participant had chewed the chewing gum 
twenty times.  
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2.11.1 Demographic information 
Participants ethnicity were collected on a self-reported basis, and more than one 
ethnicity could be chosen. Due to the wide range but low frequency of uncommon 
ethnicity’s collected, participants were grouped into four main ethnicity types; NZ-
European, Maori/Pacific Islanders, Asian and Others. Participants who identified with 
more than one ethnicity were placed in the ethnicity group they most identified 
with.  
Age of participants were recorded from the start their fixed appliance therapy i.e. 
when the initial orthodontic brackets were placed (including two by four fixed 
orthodontic treatment). Thus, time into treatment from removable appliances such 
as twin blocks, head gear, quad-helix, as well RME appliances were excluded.  
Time into treatment were recorded from when participants started their fixed 
orthodontic treatment (in the manner mentioned above) to when participants 
started phase two of this study. 
 
2.11.2 Adjustment/Activation types 
Orthodontic adjustment and activation types were divided into five major groups; 
1) No arch wires changed +/- minor bends in arch wire; 2) One arch wire changed; 
3) Two arch wire changed; 4) Power chain replacement +/- bends placed in arch 
wire; and 5) New bond up in at least one arch.  
“Bond up” is an orthodontic term used to describe the placement of fixed 
orthodontic appliances, in the case of this study, it refers to the initial appointment 
of when the braces are placed. 
Change from a two by four appliance (partial braces) to a one full arch was not 
included in group 5 unless an entire new arch was bonded. 
Use of new or continuation of inter or intra maxillary elastics, push coil and closing 
coils were included in group 4. 
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Total pain levels, that is the accumulation of the pain scores over the three days of 
recording were used for all three pain measurements; 1) pain at rest; 2) maximum 
pain; and 3) pain after chewing gum to assess adjustment/activation types.  
 
2.11.3 Psychological factors 
Pain catastrophizing as well as it’s subscales; rumination; magnification; and 
helplessness scores were tallied from the Pain Catastrophizing Scale (child version) 
questionnaire according to the key developed by Michael Sullivan (Sullivan et al. 
1995). State and Trait anxiety scores were tallied from the “How-I-Feel” 
Questionnaire (child version) from the key developed by Charles D. Spielberger 
(Spielberger et al. 1983). Dental anxiety scores were tallied from the Corah Dental 
Anxiety Scale from the key developed by Norman L. Corah (Corah 1969). All scores 
were tallied for each participant, and all scores were used as continuous data as 
opposed to categorical. Global anxiety score (last question of the questionnaire) was 
not used for data analysis.  
For analysis of psychological factors, participants were divided into three categories 
based on their cumulative pain score; 1) High pain responders; 2) Average pain 
responders; and 3) Low pain responders. The three categories were determined by 
summing each participants’ pain scores over the seven pain survey sessions. The 
participants above the 90th percentile (N=18 participants) were allocated to the high 
pain responders group, the participants below the 10th percentile (N=18 participants) 
were allocated to the low pain responders group, whilst the remaining participants 
(N=141 participants) were allocated to the average pain responders group. 
 
2.12 DNA extraction and genotyping 
DNA was extracted using a chloroform process with an ethanol precipitation on 
whole blood cells or buccal cheek cells in the instance of saliva samples. The five 
SNPs from the three candidate genes COMT (rs4680, rs6269, rs4646310), HTR2A 
(rs9316233) and NR3C1 (rs2963155) were genotyped for every participant. This 
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genotyping was replicated in 10% of the sample for quality control check purposes. 
Genotyping was completed using TaqMan SNP genotyping assays (Thermo Fisher; 
5 Caribbean Dv, Scoresby, VIC 3179, Australia) along with KAPA Probe Fast Master 
mix on Lightcycler 480 real-time PCA machine. Haplotypes of COMT were phased 
using PLINK1.9 from the SNPs rs4680 and rs6269 due to funding constraints. Ideally 
COMT haplotypes are determined from four SNPs; rs4633, rs6269, rs4818 and 
rs4680. 95.9% of COMT haplotypes could be determined from rs4680 and rs6269 
alone, resulting in 4.1% or seven participants in the study whose haplotypes would 
be misclassified. The outcome of the study is unlikely to be affected by these few 
misclassified individuals and thus we could not justify the substantial increase in the 
cost of this study to further genotype the two additional SNPs required.  
 
2.13 Data analysis 
Data analysis was completed using Statistical Package for the Social Sciences (SPSS) 
software (version 25, IBM, NY, USA). Data were analyzed using conventional 
descriptive methods. Preliminary analyses entailed normality tests and tests for 
equality of variances – assumption of normal distribution was tested using a one 
sample Kolmogorov-Smirnov test. A Repeated Measurement Friedman analysis of 
variance was used to test the effects of time (seven time points over 72 hours) on 
the two VAS variables (“current pain at teeth” and “pain at teeth after chewing”). 
The square root of the area under the curve (AUC, normally distributed) was 
calculated for VAS scores of current pain at teeth, maximum pain and pain at teeth 
after chewing, and entered as dependent variables in a general linear model, with 
age, gender, details of orthodontic adjustment, time in treatment, and psychological 
traits as covariates  (Type I error was set at 0.05). Comparison of means was 
performed using Student's t-test (if the data were normally distributed) or the Mann-
Whitney U test where data was not normally distributed. Comparisons of 
proportions used the Chi-square test. One-Way ANOVA was used to assess 
differences in pain severity across genotypes and haplotypes. 
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2.14 Ethical approval 
The pilot study for this research was approved by the University of Otago Human 
Ethics Committee in February 2016 (reference H15/124). This approval was 
extended by 8 months from the original date of February 2019 until December 
2019. Written and informed consent were obtained from all participants, and 
guardian consent was also obtained for participants under the age of 16. A copy of 
the ethics approval and extension letter is contained in Appendix 6.7, whilst a copy 
of the information sheet as well as a copy of the consent forms for participants and 
caregivers are presented in Appendix 6.4 and Appendix 6.5.  
 
2.15 Maori consultation  
Consultation with Ngai Tahu Research Consultation Committee was completed for 
the pilot study for this study in December 2015, and a copy is presented in Appendix 
6.8. Considering the research methodology and protocol has not changed, an 
extension or re-approval was not required.  
 
2.16 Funding 
This study, as well as the Pilot study for this research was supported by grants from 
the Sir John Walsh Research Institute (Fuller Scholarship), the New Zealand 
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3.1 Part one – Demographic and descriptive  
Sample  
The sample consisted of 183 patients under the age of 18 years of age currently 
being treated at the University of Otago Orthodontic Clinic with fixed appliances in 
at least one arch (Table 3.1). The sample consisted of slightly more female than male 
participants with the majority of the sample being of NZ-European descent.  
 
 
Table 3.1 Demographic Data 
Variable 
Sex  Total 
(n = 183) Female (n=97) Males (n=85) P Value 
Ethnicity (%)a     
NZ – European 83 (85.6) 77 (90.6) 0.152* 160 (87.9) 
Maori/Pacific 
Islanders 
8 (8.2) 1 (1.2)  9 (4.9) 
Asian 4 (4.1) 4 (4.7)  8 (4.4) 
Others 2 (2.1) 3 (3.5)  5 (2.7) 
     
Age in years (SD) 14.9 (1.6) 14.8 (1.4) 0.557# 14.9 (1.5) 
      *Fisher’s Exact test 
      #Unpaired Student’s T-test 
    aOne participant’s ethnicity missing 
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3.1.1 Details of orthodontic adjustment 
All 183 participants’ data were used for this part of the analysis. Most participants 
had fixed appliances in both arches (93.4%).  
 
Most of the participants (61.3%) had either a single arch wire change, or the 
placement of power chain, elastics, push coil with or without any bends being placed 
in either arch wire. A small number of patients had no arch wire changes with or 
without minor bends being placed in the arch wire.  
 
Overall, 7.1% of the pain surveys were not completed by the participants. This 
missing data was substituted from the previous pain survey based on the last 
observation carried forward mentioned in the method section. 14 participants were 
excluded from the analysis due to either; 1) poor compliance with the smartphone 
app; or 2) loss of data due to bugs associated with the app. 30 (16.4%) participants 
had to repeat phase two of the research due to the reasons mentioned above.  
 
The distribution of the study sample by the five different groups of adjustment types 
are presented in table 3.2. 
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Table 3.2 Adjustment types 
Adjustment type 
No. of patients 
(%) 
No arch wire changes +/- minor bends in arch wire 6 (3.3) 
One arch wire changed 58 (31.7) 
Two arch wire changed 26 (14.2) 
Power chain replacement +/- minor bends placed in arch wire    56 (30.6) 
New bond up in at least one arch 37 (20.2) 
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3.1.2 Pain and time 
The pain profile of participants varied greatly over the 72-hour assessment period 
for all three pain measurements; resting pain (F=213.9; p<0.001); maximum pain 
(F=265.04; p<0.001) and pain after chewing gum (F=314.04; p<0.001; Figure 3.1).  
Mean VAS pain scores and standard error of the mean (SEM) was used to assess 
pain scores over time. Participants reported some mild discomfort immediately 
following their orthodontic adjustment with a mean VAS score of 10.3% 
(SEM=1.1%) at rest and 10.8% (SEM=1.3%) after chewing gum. Compared to 
baseline, mean pain scores steadily rose and peaked on the morning of the second 
day (roughly 19 hours after baseline measurement) with a mean VAS score at rest 
of 27% (SEM=1.8%), a mean VAS maximum pain of 32.5% (standard error: 2.1%), 
and a mean VAS score after chewing gum of 38.1% (SEM=2.2%). By 8pm of the first 
day the mean VAS scores at rest (22.8%; SEM=1.6%) and after chewing gum (34%; 
SEM=2.2%) began to differ. Mean VAS pain scores started to decrease after the peak 
at 19 hours, by the evening of day 3 and morning of day 4, pain at rest did not differ 
significantly from baseline (p = 1.0).  
 
Mean VAS Pain after chewing gum scores continued to be significantly higher across 
all time points when compared to baseline (p ≤ 0.001). 
 
The first recorded mean VAS maximum pain levels (26.4%; evening of day 1) did 
not significantly differ from the evening of day 2 (30.3%; p=0.67), morning of day 3 
(23.3%; p<0.001) nor evening of day 3 (21.1%; p=0.08). By the morning of day 4, 
mean VAS maximum pain scores (16.2%) was significantly lower than the first 
recorded mean VAS maximum pain score (26.4%, p<0.001).  
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3.1.3 Adjustment/Activation type 
Cumulative pain levels after a “bond up in at least one arch” was significantly higher 
compared to all other adjustment types for all three pain measurements: Pain at rest 
(p≤0.018); pain after chewing gum (p≤0.002); and, maximum pain (p≤0.008). 
The adjustment type: “bond up in at least one arch” accounted about 20% of the variance 
in self-reported pain scores during the study.  
 
Cumulative pain levels after chewing gum was significantly higher after “two arch wire 
replaced” when compared to “no arch wire change +/- minor bends placed in arch wire” 
(p=0.042) and “ power chain replacement +/- minor bends placed in arch wire” (p=0.039). 
There were no other statistically significant differences in cumulative pain levels experienced 
at rest, after chewing gum or with maximum pain levels when comparing the other details 
of adjustment types (Figure 3.2). 
 
Cumulative pain levels recorded over the three day research period for at rest, after chewing 
gum and with maximum pain was not influenced by age (F ≤ 2.06; p ≥ 0.15), gender (F ≤ 
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3.2 Part two – Psychological factors  
A total of 177 participant data were used for the psychological analysis: six participants were 
either missing or had incomplete questionnaires.  
 
High pain responders showed a trend to have a higher total pain catastrophizing, rumination, 
helplessness, magnification, A-State and A-Trait scores when compared to low pain 
responders. However, out of the scales mentioned, only the magnification scores were 
significantly higher in the high pain responders’ group (2.8) when compared to the lower 
pain responders (1.4) group (p=0.048). 
 
No statistical difference in the dental anxiety scale score was found between high pain 
responders, average pain responders or low pain responders (p=0.966). 
Pain catastrophizing, rumination, helplessness, magnification, A-state, A-trait and dental 
anxiety scale scores did not differ when comparing average pain responders to high pain 
responders nor to low pain responders (Table 3.3). 
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Table 3.3 Average psychological trait scores across three different pain responder groups. Data represents mean values (standard deviation) 
 
Pain Profile Group 
 
Combined 
(n = 177)  High Pain (n =18) Average pain (n=141) Low Pain (n=18) P Value 
Catastrophizing (SD) 14.7 (7.1) 15.1 (7.9) 11.2 (7.1) 0.141 14.7 (7.8) 
Rumination (SD) 7.1 (3.3) 7.4 (3.5) 6.2 (3.7) 0.391 7.2 (3.5) 
Magnification (SD) 2.8 (1.8) 2.5 (2) 1.4 (1.7) 0.042* 2.4 (1.9) 
Helplessness (SD) 4.8 (2.9) 5.2 (3.6) 3.7 (3) 0.205 5 (3.5) 
A-State (SD) 29.1 (3.4) 29.4 (5.1) 27.5 (3.9) 0.319 29.1 (4.9) 
A-Trait (SD) 34.3 (6.1) 33.4 (7.5) 29.7 (7.9) 0.108 33.1 (7.5) 
Mean DAS score (SD) 7.8 (2.8) 7.9 (2.9) 7.8 (2) 0.966 7.9 (2.8) 
*R Squared = 0.04 
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3.3 Part three – Genetics 
3.3.1 SNPs 
Of the 183 participants in total, four participants DNA samples were not collected, a further 
seven DNA samples failed when genotyped. The remaining 173 DNA samples were 
analyzed, though a further few more failed in specific SNPs (one for rs6269, 10 for rs4680, 
three for rs4646310, four for rs2963155, and 10 for rs9316233).  Peak and cumulative 
(total pain) values were used to assess participant pain levels for pain at rest, maximum pain 
and pain after chewing gum. 
 
The various SNP genotypes and peak pain values experienced at teeth are presented in 
Table 3.4, whilst the various SNP genotypes and cumulative pain values experienced at teeth 
are presented in Table 3.5. The participant with AA genotype of COMT gene at position 
rs4646310 reported almost double the peak pain value for at rest, maximum pain and pain 
after chewing gum when compared to the AG and GG genotypes (p=0.048). Cumulative 
pain for the AA genotype of COMT rs4646310 was almost triple at rest, maximum pain 
and pain after chewing gum when compared to the AG and GG genotypes (p=0.048). The 
remaining SNPs did not show any difference in reported peak pain or cumulative pain levels 





 Table 3.4 Peak values of VAS pain scores (%) by SNPs 
Candidate SNPs/Genotypes Frequency (%) Current Pain at teeth  Maximum Pain  Pain after chewing gum  
  (Mean ± SD) (Mean ± SD) (Mean ± SD) 
rs6269 (COMT)     
AA 70 (40.7) 34.1 ± 22 40.3 ± 23.8 50.6 ± 26.9 
AG 84 (48.8) 35 ± 25.8 41.3 ± 28.6 46.6 ± 30.2 
GG 18 (10.5) 39.7 ± 23.6 46.1 ± 24.6 52.6 ± 26.7 
rs4680 (COMT)     
AA 54 (33.1) 34.3 ± 22.6 41.7 ± 23.9 52.2 ± 26.3 
AG 79 (48.5) 32.9 ± 23.9 39 ± 26.7 46.3 ± 28.8 
GG 30 (18.4) 40.8 ± 25.2 45.4 ± 27.3 47.5 ± 30.5 
rs4646310 (COMT)     
AA 1 (0.6) 70 ± NA 75 ± NA a 76 ± NA 
AG 56 (32.9) 30 ± 21.3 36.1 ± 24.6 43 ± 28.8 
GG 113 (66.5) 38 ± 24.7 44.7 ± 26.7 52 ± 28 
rs2963155 (NR3C1)     
AA 106 (62.4) 34.6 ± 26.1 40.7 ± 26 47.9 ± 27.5 
AG 58 (34.1) 35.5 ± 24.3 43.5 ± 27.4 50.6 ± 30.9 
GG 6 (3.5) 38.5 ± 25.3 40.7 ± 28.4 48.5 ± 26.2 
rs9316233 (HTR2A)       
CC 101 (62) 34.9 ± 25.8 41 ± 27 48 ± 28.9  
CG 56 (34.4) 36.5 ± 23.7 43.4 ± 27.4 51.4 ± 29.8 
GG 6 (3.7) 30.5 ± 20.9 32 ± 20.2 39.5 ± 20 




Table 3.5 Area under the curve (arbitrary values) of VAS pain scores by SNPs 
Candidate SNPs/Genotypes Frequency (%) Resting Pain at teeth Maximum pain  Pain after chewing gum 
  (Mean ± SD)  (Mean ± SD) (Mean ± SD) 
rs6269 (COMT)     
AA 70 (40.7) 110.1 ± 97 137.8 ± 106.3 182.2 ± 127.1 
AG 84 (48.8) 118.7 ± 119.8 148.1 ± 132.6 176.6 ± 146.1 
GG 18 (10.5) 158 ± 107.8 198.2 ± 139.6 218.7 ± 144 
rs4680 (COMT)     
AA 54 (33.1) 112.2 ± 96.1 145.7 ± 106.7 183.9 ± 122.4 
AG 79 (48.5) 110.5 ± 111 136.8 ± 121.8 175.1 ± 143 
GG 30 (18.4) 146.5 ± 116.2 175.6 ± 145.9 190.1 ± 146.7 
rs4646310 (COMT)     
AA 1 (0.6) 366 ± NA 369 ± NA a 349 ± NA 
AG 56 (32.9) 101.9 ± 92 128.6 ± 117 157.2 ± 130.1 
GG 113 (66.5) 128.5 ± 115.3 161.3 ± 125.4 198.2 ± 141.6 
rs2963155 (NR3C1)     
AA 106 (62.4) 115.1 ± 106.9 144.8 ± 120.1 176.2 ± 134.4 
AG 58 (34.1) 121.5 ± 112.7 156.3 ± 128.5 194.9 ± 146.9 
GG 6 (3.5) 170.8 ± 150.5 175.5 ± 161.8 207.3 ± 162.9 
rs9316233 (HTR2A)       
CC 101 (62) 116.6 ± 115.7 145.1 ± 125.6 173.9 ± 138.4 
CG 56 (34.4) 132.6 ± 115.6 161.9 ± 133.3 208 ± 148.3 
GG 6 (3.7) 81 ± 61.4 102.5 ± 71.8 119.5 ± 68.1 
aP = 0.046     
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3.3.2 COMT Haplotypes 
Mean peak pain (highest VAS scores) and cumulative pain for the three measures; resting 
pain, maximum pain and pain after chewing were plotted against the five different haplotypes 
of the COMT gene (Figure 3.5 and Figure 3.6). Only two participants had the haplotype 
HPS/HPS and were excluded from the data analysis. 
 
HPS/LPS haplotype had the highest mean peak VAS pain scores at rest (43.27) and for 
maximum pain (48.64), whilst LPS/LPS haplotype had the highest mean peak VAS pain 
scores for after chewing gum (51.33). LPS/APS haplotype had the lowest mean peak VAS 
pain scores at rest (33.38) and for pain after chewing gum (45.44), whilst APS/HPS haplotype 
had the lowest mean VAS peak scores for maximum pain (36.83). However, there was no 
statistically significant difference found between any of the COMT haplotypes and highest 
mean peak VAS pain scores for any of the three VAS pain measurements (0.33≤p≤0.42) 
 
LPS/LPS haplotype had the highest cumulative pain VAS scores at rest (157.4), for maximum 
pain (192.27), and pain after chewing gum (211.8). LPS/APS haplotype had the lowest 
cumulative pain VAS scores for at rest (113.16) and for pain after chewing gum (171.48), 
whilst APS/HPS haplotype had the lowest cumulative pain VAS scores for maximum pain 
(120.08). However, no statistically significant difference was found between any of the 
COMT haplotypes and cumulative VAS pain scores for any of the three VAS pain 
measurements (0.27≤p≤0.56) 
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The results of this study indicated that:  
- orthodontic pain varies with time after an orthodontic adjustment, with pain 
peaking roughly one day after the adjustment and gradually decreasing there-
after.  
- Pain is influenced by the type of activation, especially in “new bond ups” 
which significantly results in higher self-reported pain levels.  
- The psychological and genetic factors investigated in this study have very little 
influence on self-reported pain scores.  
  
The sample size was smaller than the original 300-participant goal, for various  
reasons; 1) The resignation of the phlebotomist directly affected patient entering 
“Phase one” of this study; 2) The smartphone app bug resulted in increased time 
spent on repeating measurements; 3) Participant compliance during research (not 
completing questionnaires, failing to return the research phone on time and etc.); 4) 
the limitation of six research phones constrained the number of participants that 
could be recruited at any one given time (though, having more phones would make 
it more difficult for the primary investigator to manage); and 5) A longer research 
time frame could have resulted in more participants being recruited for the study.  
 
This study utilized an ecological momentary assessment approach via a smartphone 
app to investigate patient’s pain experiences over a three-day period. This method 
has been shown to be an effective way in measuring orthodontic pain (Sew Hoy et 
al. 2018) and utilizing this approach allowed participants to record their pain 
experiences “in real-time, in real-world settings, over time and across contexts” 
(Kirchner and Shiffman 2013). This approach has many advantages; risk of recall bias 
is reduced; data entry mistakes are minimized, and digital data also allows for easier 
analysis and storage. However, the app was not without its glitches, some of which 
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resulted in the loss of data when the app was forced-closed, the phone was switched 
off, ran out of power, or in some cases, the data was lost for unknown reasons. 
Unfortunately, the smartphone app was not compatible with all smartphones, which 
resulted in an increase in research costs due to the need to purchase dedicated 
research smartphones. On some occasions, a bug in the app would occur that 
resulted in the failure to send the pain data information for unknown reasons. As 
such, research phones had to be returned immediately following the completion of 
all seven pain survey sessions or risk losing the survey data had the phone run out 
of battery, in which case the data can then be recovered manually. Despite the bugs 
associated with the app, data collection was only repeated on 30 (16%) participants, 
whilst only eight (4%) participants data were completely lost. Obviously, some 
debugging is still required for future use of the application, however, when the 
application worked, it worked very well, suggesting that the EMA approach is still an 
accurate and reliable method of assessing orthodontic pain. 
 
Participant pain levels following orthodontic adjustment have been well documented, 
and studies constantly show a rise in pain following adjustment and peaking some 
24 to 48 hours after the adjustment. Pain levels gradually decreased following this 
peak but never quite reach zero, which is most likely due to the short period of 
follow up post adjustment.  The results of this study have shown a similar trend, 
with participants reporting some mild discomfort immediately following adjustment, 
pain increasing and peaking on the morning of day 2 (roughly 19 hours following 
the adjustment) and gradually decreasing afterwards. A study by Furstman & Bernick 
in 1972 have stated that a “pain free” period of up to two hours exists following 
adjustment, this report however, is anecdotal and may be due to the patient’s own 
distinction that, although there is some discomfort, it is not necessarily severe 




Pain levels reported after chewing gum was consistently higher than pain at rest 
across all time points, which contradicts studies that showed shown chewing gum 
could help alleviate pain (Benson, Razi, and Al-Bloushi 2012) and reduce the use of 
analgesics (Ireland et al. 2016). Chewing gum in this study was used to simulate 
mastication, not to alleviate pain levels. Participants were instructed to chew the gum 
only twenty times per session and not to chew the gum otherwise. It is likely that 
patients who chewed gum for pain relief chewed the gum more frequently and for 
a longer period. The difference in the use of chewing gum may explain the higher 
levels of reported pain in this study. The placebo effect may also have been 
conferred to the chewing of gum had clinicians suggest patients use it for pain relief, 
which was not the case in this study. 
 
“Maximum pain” levels were not recorded at baseline, and the first recording of this 
parameter occurred at session two (evening of day one), by which time pain the 
levels had already increased. This may explain the significantly lower mean maximum 
pain levels reported on the morning of day four (16.25%; CI: 13.30% - 19.06%) 
compared to the evening of day one (26.45%; CI: 22.86% - 30.04%). Unlike “resting 
pain” or “pain after chewing gum”, “maximum pain” levels are more subject to bias, 
and participants may also have difficulty understanding this question due to its 
complexity. The literature is divided on the effect that recall bias has on self-reported 
pain levels-some studies reported that participants report higher pain levels when 
asked about their painful experience retrospectively (Kent 1985; Linton and Melin 
1982), whilst other studies report the opposite effect (Norvell, Gaston-Johansson, 
and Fridh 1987). Hunter et al (1979) found retrospective recall of pain to be 
accurate, and that memory for pain show little change over time. 
 
As far as we are aware this is the only study that has investigated the effects of 
different orthodontic adjustments (e.g. new bonds up, wire changes) on a patient’s 
perception of pain. Surprisingly, patient pain scores were affected by different types 
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of orthodontic adjustment, with a pattern for a patient to perceive more pain after 
the following adjustments types ranked in descending order: 1) “new bond up at 
least one arch”; 2) “two arch wires changed”; 3) “replacement of power chain, use 
of elastics etc.”; 4) “one arch wire change”; 5) “no arch wire changes with or without 
minor bends”. Among all the covariates included in the regression model, the effect 
of orthodontic adjustment explained the highest variance in pain response, 
accounting for 20% in patient pain variability.  
 
There are a wide variety of orthodontic treatment variables which may influence 
orthodontic pain, these could include ligation types: stainless steel ligatures or o’rings; 
bracket size, 0.018” or 0.022”; bracket types: self-ligating or traditional; arch-wire 
used: stainless steel or nickel-titanium etc. The main theme is centered around the 
amount of force applied to the tooth or in orthodontic terms: “the amount of 
activation”. Some studies have shown a relationship between the amount of force 
applied and the amount of pain perceived (Luppanapornlarp et al. 2010; Singh et al. 
2019), this relationship however, is quite controversial. It seems more likely that the 
introduction of a new force system rather than the amount of force has a larger 
impact on orthodontic pain. This can be observed where “New bond-ups” in this 
study perceive the most pain (hence the introduction of a new force system), 
comparatively, previous studies have found no difference in pain perception when 
different initial arch wires with different force-deflection ratios were used (Jones and 
Chan 1992), nor during the alignment phase with the same wire on patient’s with 
varying degrees of crowding (Jones and Richmond 1985). 
 
When compared to low-pain responders (bottom 10%), high-pain responders (top 
10%) tended to have higher pain catastrophizing scores (14.7 vs 11.2) across all 
subscales (rumination, magnification and helplessness) and have higher A-State (29.1 
vs 27.5) and A-Trait (34.3 vs 29.7) scores. However, only the magnification subscale 
scores were statistically different between the two groups. The difference in pain 
57 
 
catastrophizing scores between high and low pain responders are consistent with 
most reports in the literature which has shown that pain catastrophizing levels are 
predictors for patient’s self-reported pain levels. Conversely, the lack of significant 
difference in state and trait anxiety levels between the two pain groups were 
consistent with a previous study at the University of Otago which also did not find 
A-state and A-trait scores to differ between high and low pain responders after the 
placement of orthodontic separators (Beck 2013).  
 
Dental anxiety scores were almost identical between high and low pain responders, 
with both groups having a mean DAS score of 7.8. This contrasts most literature, 
where dental anxiety levels have been shown to be good predictors of patient’s pain 
experiences during routine dental procedures. Orthodontic procedures often don’t 
require the use of local anesthetic and/or handpieces, thus are quite different from 
routine general dental procedures. More recently, a orthodontic version of the 
Modified Dental Anxiety Scale (MDAS) (Humphris, Morrison, and Lindsay 1995) has 
been developed by Roy and Dempster (2018). This modified questionnaire (MDAS-
Ortho) is short and easy to complete and consists of only five questions. In future 
studies, the use of the MDAS-Ortho instead of the Corah Dental Anxiety Scale may 
be more suitable for assessing dental anxiety related to orthodontics. More closely 
related to orthodontic procedures, a previous study at the University of Otago has 
found high pain responders to have significantly higher DAS scores compared to 
low pain responders after the placement of separating elastics (mean: 9.4 vs 6.5, 
p=0.043) (Beck 2013). It is possible dental anxiety and pain catastrophizing has a 
greater influence on patient pain levels during the initial stages of orthodontic 
treatment e.g. placement of separating elastics, compared to participants in this study 
who have already commenced orthodontic treatment.  
 
Blood samples remain the gold standard source of DNA and are much preferred 
for genotyping compared to saliva samples. However, drawing blood requires a 
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trained health professional and due to the invasive nature of the procedure, it can 
be daunting for some participants especially in orthodontics, where the majority of 
patients are young adolescents. Alternatively, the acquisition of DNA samples via 
saliva are much more user-friendly and painless. Of the 179 DNA samples collected 
in this study, only 106 participants (59.2%) gave a blood sample. The concerns with 
DNA samples from saliva are due to effects of microbes found in the oral cavity and 
with enzymes found in saliva. Compared to blood, a smaller yield of DNA is 
extracted from the same amount of saliva (21.1µg vs 253.6µg), it is less amplifiable 
(37.3% vs 97.6%) and has a lower genotyping call rate (88.8% vs 99.1%) (Hu et al. 
2012). The real-life effects of these drawbacks are more difficult to quantify, in this 
study, 7 (10%) of saliva samples failed completely when genotyped, and a further 10 
(13.7%) to 28 (38.4%) samples failed for specific SNPs. In comparison, no blood 
samples failed when genotyped. Blood samples are undoubtedly a much better 
source of DNA for genotyping, but without saliva samples, the sample size of this 
study would have almost been halved and the power of this study would have been 
significantly diminished.   
  
Genetic studies often require a large sample size in order to compensate for the 
relatively low frequencies of minor alleles. The number of participants with minor 
allele frequencies in this study ranged from 1 (0.6%, rs4646310 COMT) to 30 
(18.4%, rs4680 COMT). Participants with the minor allele of the COMT gene (GG 
for rs6269 and rs4680, AA for rs4646310) showed a slightly higher tendency to 
report more pain, however only one statistically significant finding was found due to 
the large standard deviation value. The participant with the minor allele (AA) for 
rs4646310 COMT gene reported almost three times the amount of cumulative pain 
and double the amount of peak pain compared to the GG and AG genotypes; the 
single participant with this minor allele had just undergone a bond up (to which we 
know is highly associated with higher pain levels), however, it may still be an 
interesting finding due to the very high levels of reported pain by this participant. 
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Individuals with minor allele GG for rs6269 has been shown to report higher levels 
of thermal pain (Kim et al. 2006), whilst minor allele G for rs4680 has been shown 
to be linked with schizophrenia (Shifman et al. 2002). Both of these findings are in 
accord with the trends found in this research, however minor allele for rs4680 has 
also been shown to be protective against experimental pain (Diatchenko et al. 2005). 
Comparatively, the alleles AG for rs4646310 COMT was found to be a risk factor 
for TMD (Michelotti et al. 2014) whilst in this study, the participants with the allele 
AG tended to report less pain.  
 
Due to limited funding available for the research the COMT haplotypes, low pain 
sensitivity (LPS), average pain sensitivity (APS) and high pain sensitivity (HPS) were 
determined from the two SNPs (rs6269 and rs4680)  instead of the usual four SNPs  
(rs6269, rs4818, rs4633 and rs4680) (Diatchenko et al. 2005). Diatchenko stated 
that the three most common haplotypes accounted for 95.9% of all varying 
haplotypes. Fortunately, these three haplotypes can be determined from two SNPs 
alone (rs6269 and rs4680), but the use of two SNPs resulted in 4% or seven of the 
participants whose haplotypes could not be determined. The small number was 
deemed unlikely to affect the results. Additionally, two participants had a haplotype 
which was not described by Diatchenko (with the haplotype HPS/HPS), and these 
participants were excluded from the results due to their low number. Pain 
perception across all five haplotype variations were similar, with LPS/APS and 
APS/APS participants tending to have reported less pain during orthodontic 
treatment on average. Compared to other studies that have consistently shown that 
the HPS and HPS/APS haplotype were significantly associated with TMD-related 
pain (Smith et al. 2011) as well as higher thermal, pressure and ischemic pain 
perception during experimental pain procedures (Diatchenko, Nackley, et al. 2006). 
 
The minor alleles (G) of the HTR2A and NR3C1 gene have been shown to have a 
protective affect against TMD-related pain (OR:0.62 for NR3C1)(Smith et al. 2011) 
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which coincides with the patterns found in this study. The minor allele genotype 
(GG) for the gene HTR2A did tend to perceive less pain on average (32, GG. 43.4, 
CG. 41, CC), however no statistically significant findings were found. There were 
only 6 participants with the minor allele for either gene, having a larger sample size 
and thus a larger group of participants with the minor allele may yield significant 
findings. 
 
This study has failed to identify significant differences in participant pain perception 
across multiple SNPs of the COMT, HTR2A and NR3C1 gene. However, it is of 
importance to note that as a post hoc analysis was not performed, the analysis for 
the genetic data should be considered exploratory, the occurrence of type II error 
cannot be ruled out, and the null hypothesis cannot be fully accepted. 
 
The debate between nature and nurture is still questionable, and with over 46,831 
genes  in the human genome (Salzberg 2018), the effect of these genes, how they 
interact and ultimately the inheritability of different traits are still poorly understood. 
Multiple genes may interact together to have a synergistic effect on certain traits, but 
just as important are the timing as to when these genes are switched “on” or “off”. 
The switching “on” and “off” of these genes may be governed by the intron sections 
which does directly affect the structure of the protein itself but may still have a 
significant impact on the ultimate phenotype. Literature on the effects of specific 
genes and their interactions are still in its infancy but will continue to expand as the 
cost of genotyping decreases and our understanding of the human genome 
increases. It may be possible that genetics has a large influence on an individual’s pain 
perception, but the specific gene or group of genes which regulate pain perception 
has yet to be identified.   
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4.2 Conclusion and future directions 
The use of an ecological momentary assessment approach with a smartphone app 
is a convenient method in assessing patient’s pain levels in real time. Further 
improvements in the smartphone app could make it more accessible and used more 
readily, and this could include the ability to install our App for monitoring 
orthodontic pain on all Android and iOS phones. Most of the population already 
own a smartphone - being able to install and use the smartphone app on patient’s 
phones would eliminate the need for research phones to be issued. The resolution 
of bugs would also eliminate the need to repeat readings due to loss of data or 
incorrect recording of data due to factors not involving compliance. 
 
Self-reported orthodontic pain was not influenced by age, gender, time into 
treatment, nor ethnicity. Activation/adjustment type had the greatest influence on 
self-reported orthodontic pain, in particular; significantly higher pain levels were 
reported after a “new bond up in at least one arch”, which is the single biggest 
contributing factor to orthodontic pain and accounted for 20% of the variance in 
reported pain levels. 
  
Psychological factors such as pain catastrophizing, anxiety (A-State, A-Trait) and 
dental anxiety scores are not strong predictors for orthodontic pain levels during 
fixed orthodontic treatment. However, high pain responders did have a significantly 
higher magnification score compared to low pain responders.  
 
The genetic markers investigated in this study seem to have little influence over 
orthodontic pain during fixed orthodontic treatment, in particular SNPs of the 
COMT gene (rs6269, rs4680, rs464310), NR3C1 gene (rs2963155), HTR2A gene 
(rs9316233), as well as haplotypes of the COMT gene appears to not be significantly 




This study has concluded that the psychological and genetics factors investigated 
have limited influence over self-reported orthodontic pain levels during fixed 
orthodontic treatment among adolescents. However, other studies have found 
contradictory evidence, due to the larger sample sizes required for genetic studies. 
A future study with a larger sample size may add further support to our findings. By 
knowing which factors contribute to orthodontic pain paves the road for 
personalized medicine in dentistry, with the aim to improve the patient’s overall 
comfort and quality of life during orthodontic treatment. This could include: 
recommending patients take pre-operative pain relief; using materials with different 
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6.3 Flow of “My Braces Experience” application 
 
Figure 1 
Screen after opening the “My Braces 
Experience” app. Here the primary 
investigator would enter the participants’ 




Bottom of screen from Figure 1 above, here 
the gender can be selected. Clicking on 






Some information regarding the research 
is provided. Note, the inclusion criteria 
had been changed to include all 




This screen is no longer relevant as patients 
do not have to have an arch wire change to 
participate in the study. However, the app 
will not allow the participant to proceed 






This first questions asks about whether the 
participant has had any pain relief in the last 
4 hours. Either “yes” or “no” can be selected. 
 
Figure 5 
Some more information for the 
participant. After which this screen, the 






If the participant answered yes to the 
previous question, they could now select 
the type of pain relief they have had in the 




Using this visual analogue scale, participants can now describe their current pain levels, 






An example of a participant moving the slider to the “worst pain imaginable”. 
 
Figure 10 
Next screen asks the participant about 
whether they have had any pain in the jaw, 
temple, in the ear, or in front of the ear. 
Either a “yes” or “no” can be selected. 
A diagram showing these different pain 
areas are given to each participant in the 
“information regarding “My Braces 






If “yes” was selected on the previous 
screen, participants can now specify 
where the pain was and on which side. 
More than one option can be selected. 
 
Figure 12 
An example of a participant selecting pain on 






This screen asks the participants if they 
have had a headache that included the 
temple regions of the head recently. Either 
“yes” or “no” can be selected. 
 
Figure 13 
The participant is then asked to describe the pain in that region on a visual analogue scale. 






An example of the participant selecting that 
they have headache which included pain on 
the right side of the temple.  
 
Figure 15 
If yes was selected in the previous screen, 
the participant is now asked which side 
the headache was one. More than more 






Participants are then asked to chew a piece of Extra sugar free gum for 20 strokes.   
 
Figure 17 
The participant is then asked to describe the headache pain in the temple region on a visual 






Participants are then asked to describe the maximum pain they experience whilst chewing 
the gum. As an example, the participant has chosen the “worst pain imaginable”. 
 
Figure 20 
This last screen signals the end of the first 
sessions. It also alerts the participants that 
the next survey session is due to be 






Again, participants are asked about their pain 
relief. From the second pain survey sessions 
onwards, participants are asked about pain 
relief consumption over the last 12 hours (as 
opposed to the four hours asked at baseline).  
 
Figure 21 
At 8pm on the first day, the application will 
play an audio alert to inform the 
participant that it is time for the second 







This question was not included in the survey session at baseline, it asks the participant to 
describe the maximum pain they have experienced since the last survey session.  As an 
example, the participant has chosen the “worst pain imaginable”. 
 
Figure 23 






Again, if yes is selected. Participants are then 
asked where and on which side the pain was 
on. More than one option can be chosen. As 
an example, the participant had selected in 
front of the ear on the right hand side.   
 
Figure 25 
Once again, participants are asked if they 
have had any pain in the ear, in front of 
the ear, in the jaw or temple region. 






This question was not included in the baseline survey session. It asks the participant what 
the maximum amount of pain they have experienced in that area (from question 4a, figure 
25) since the last survey session. As an example, the participant has moved the cursor to 
the end of the “worst pain imaginable”. 
 
Figure 27 
Again, if yes is selected, participants are asked to describe their pain in that region. As an 






Again, the participant is asked if they have 
had any headaches which include the 




Again, the participants are asked which side 
the headache was on. More than more 
option can be selected. As an example, the 
participant has selected the left-hand side of 






Again, the participant is asked to describe the current headache pain in the area selected 
on a visual analogue scale. As an example, the participant has placed the cursor on the 
“worst pain imaginable”. 
 
Figure 32 
This question is again not included in the baseline survey session. It asks the patient to 
describe the maximum pain they have had in terms of headaches in the temple region 
selected since the last survey session. As an example, the participant has placed the cursor 





Again, the participant is asked to describe the maximum pain they have experience whilst 












This screen marks the end of survey 
session two. It alerts the participant that 
the next survey session is to be 
completed at 8:00am tomorrow morning. 
All subsequent survey sessions follow the 
same flow from figure 21 – 35. A total of 
seven survey sessions are to be 
completed over the approximate three-
day period (roughly 72 hours). 
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6.8 Maori consultation  
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